Beneficial opioid management strategies: A review of the evidence for the use of opioid treatment agreements von McAuliffe Staehler, Tuesday M., Palombi, Laura C.

Volltext

A new setup for the quantitative analysis of drying by the use of gas-phase FTIR-spectroscopy von Scheepers, F., Staehler, A., Staehler, M., Carmo, M., Lehnert, W., Stolten, D.

Volltext

Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings von Beck, J., Procopio, G., Bajetta, E., Keilholz, U., Negrier, S., Szczylik, C., Bokemeyer, C., Bracarda, S., Richel, D.J., Staehler, M., Strauss, U.P., Mersmann, S., Burock, K., Escudier, B.

Volltext

Dual energy can accurately differentiate uric acid-containing urinary calculi from calcium stones von Spek, A., Strittmatter, F., Graser, A., Kufer, P., Stief, C., Staehler, M.

Volltext

Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial von Staehler, M., Motzer, R.J., George, D.J., Pandha, H.S., Donskov, F., Escudier, B., Pantuck, A.J., Patel, A., DeAnnuntis, L., Bhattacharyya, H., Ramaswamy, K., Zanotti, G., Lin, X., Lechuga, M., Serfass, L., Paty, J., Ravaud, A.

Volltext

Adjuvant therapy in renal cell carcinoma: the perspective of urologists von Spek, Annabel, Szabados, B., Casuscelli, J., Stief, C., Staehler, M.

Volltext

Axitinib versus sorafenib in advanced renal cell carcinoma: subanalyses by prior therapy from a randomised phase III trial von Escudier, B, Michaelson, M D, Motzer, R J, Hutson, T E, Clark, J I, Lim, H Y, Porfiri, E, Zalewski, P, Kannourakis, G, Staehler, M, Tarazi, J, Rosbrook, B, Cisar, L, Hariharan, S, Kim, S, Rini, B I

Volltext

Systemic therapy in metastatic renal cell carcinoma (mRCC): an evidence-based recommendation of the German interdisciplinary RCC guidelines group von Grünwald, V., Bergmann, L., Brehmer, B., Eberhardt, B., Kastrati, Karin, Gauler, T., Gehbauer, G., Gschwend, J., Johannsen, M., Klotz, T., Protzel, C., Schenck, M., Staehler, M.

Volltext

PSMA PET/CT for tyrosine-kinase inhibitor monitoring in metastatic renal cell carcinoma von Mittlmeier, L. M., Unterrainer, M., Todica, A., Cyran, C. C., Rodler, S., Bartenstein, P., Stief, C. G., Ilhan, H., Staehler, M.

Volltext

18F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing tyrosine kinase or checkpoint inhibitor therapy: preliminary results von Mittlmeier, L. M., Unterrainer, M., Rodler, S., Todica, A., Albert, N. L., Burgard, C., Cyran, C. C., Kunz, W. G., Ricke, J., Bartenstein, P., Stief, C. G., Ilhan, H., Staehler, M.

Volltext

Advanced Molecular Imaging in Histologically Verified Metanephric Adenoma von Mittlmeier, L.M., Unterrainer, M., Todica, A., Clevert, D.A., Cyran, C.C., Schmoeckel, E., Rodler, S., Bartenstein, P., Stief, C.G., Ilhan, H., Staehler, M.

Volltext

Statistical investigations of basis weight and thickness distribution of continuously produced fuel cell electrodes von Stähler, M., Friedrich, I.

Volltext

Malnutrition and clinical outcome in urological patients von Karl, A, Staehler, M, Bauer, R, Tritschler, S, Hocaoglu, Y, Buchner, A, Hoffmann, J, Kuppinger, D, Stief, C, Rittler, P

Volltext

Outcome of treatment discontinuation in patients with metastatic renal cell carcinoma and no evidence of disease following targeted therapy with or without metastasectomy von Johannsen, M., Staehler, M., Ohlmann, C.-H., Flörcken, A., Schmittel, A., Otto, T., Bex, A., Hein, P., Miller, K., Weikert, S., Grünwald, V.

Volltext

A multinational phase II trial of bevacizumab with low-dose interferon-α2a as first-line treatment of metastatic renal cell carcinoma: BEVLiN von Melichar, B., Bracarda, S., Matveev, V., Alekseev, B., Ivanov, S., Zyryanov, A., Janciauskiene, R., Fernebro, E., Mulders, P., Osborne, S., Jethwa, S., Mickisch, G., Gore, M., van Moorselaar, R.J.A., Staehler, M., Magne, N., Bellmunt, J.

Volltext

Scalable Implementation of Recombination Catalyst Layers to Mitigate Gas Crossover in PEM Water Electrolyzers von Stähler, A., Stähler, M., Scheepers, F., Lehnert, W., Carmo, M.

Volltext

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma after Nephrectomy von Ravaud, Alain, Motzer, Robert J, Pandha, Hardev S, George, Daniel J, Pantuck, Allan J, Patel, Anup, Chang, Yen-Hwa, Escudier, Bernard, Donskov, Frede, Magheli, Ahmed, Carteni, Giacomo, Laguerre, Brigitte, Tomczak, Piotr, Breza, Jan, Gerletti, Paola, Lechuga, Mariajose, Lin, Xun, Martini, Jean-Francois, Ramaswamy, Krishnan, Casey, Michelle, Staehler, Michael, Patard, Jean-Jacques

Volltext

Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell carcinoma: a prospective evaluation von Staehler, Michael, Haseke, N, Roosen, A, Stadler, T, Bader, M, Siebels, M, Karl, A, Stief, C G

Volltext

Clinical Usage of Different Guidelines in Routine Management, Therapy and Follow-Up of Patients with Renal Cell Cancer in Germany von Spek, A., Szabados, B., Ziegelmüller, B., Stief, C., D'Anastasi, M., Staehler, M.

Volltext

Frequency dependence of high-cycle fatigue behavior of CVI C/SiC at room temperature von Staehler, James M., Mall, Shankar, Zawada, Larry P.

Volltext